Authentification abonné
lvrea
Accueil Tous les numéros Volume 27 / Numéro 3 (Mai 2018) Méd. Intensive Réa., 27 3 (2018) 217-227 Références
Accès gratuit
Numéro
Méd. Intensive Réa.
Volume 27, Numéro 3, Mai 2018
Infectieux
Page(s) 217 - 227
Section Mise au point / Update
DOI https://doi.org/10.3166/rea-2018-0049
Publié en ligne 19 juin 2018
  • Celis R, Torres A, Gatell JM, Almela M, Rodríguez-Roisin R, Agustí-Vidal A, (1988) Nosocomial pneumonia. A multivariate analysis of risk and prognosis. Chest 93: 318–324 [CrossRef] [PubMed] [Google Scholar]
  • American Thoracic Society; Infectious Diseases Society of America, (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171: 388–416 [CrossRef] [PubMed] [Google Scholar]
  • Ison MG, Michaels MG, (2009) The AST infectious diseases community of practice. RNA respiratory viral infections in solid organ transplant recipients. Am J Transplant 9:S166–S172 [CrossRef] [Google Scholar]
  • Hammond SP, Gagne LS, Stock SR, Marty FM, Gelman RS, Marasco WA, Poritz MA, Baden LR, (2012) Respiratory virus detection in immunocompromised patients with FilmArray® respiratory panel compared to conventional methods. J Clin Microbiol 50: 3216–3221 [CrossRef] [PubMed] [Google Scholar]
  • Kim HK, Oh SH, Yun KA, Sung H, Kim MN, (2013) Comparison of Anyplex II RV16 with the xTAG® respiratory viral panel and Seeplex RV15 for detection of respiratory viruses. J Clin Microbiol 51: 1137–1141 [CrossRef] [PubMed] [Google Scholar]
  • Nolte FS, Marshall DJ, Rasberry C, Schievelbein S, Banks GG, Storch GA, Arens MQ, Buller RS, Prudent JR, (2007) MultiCode- PLx system for multiplexed detection of seventeen respiratory viruses. J Clin Microbiol 45: 2779–2786 [CrossRef] [PubMed] [Google Scholar]
  • Hong HL, Hong SB, Ko GB, Huh JW, Sung H, Do KH, Kim SH, Lee SO, Kim MN, Jeong JY, Lim CM, Kim YS, Woo JH, Koh Y, Choi SH, (2014) Viral infection is not uncommon in adult patients with severe hospital-acquired pneumonia. PLoS One 9: e95865 [CrossRef] [PubMed] [Google Scholar]
  • Loubet P, Voiriot G, Houhou-Fidouh N, Neuville M, Bouadma L, Lescure FX, Descamps D, Timsit JF, Yazdanpanah Y, Visseaux B, (2017) Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: a single-center retrospective study. J Clin Virol 91: 52–57 [CrossRef] [PubMed] [Google Scholar]
  • Shorr AF, Zilberberg MD, Micek ST, Kollef MH, (2017) Viruses are prevalent in non-ventilated hospital-acquired pneumonia. Respir Med 122: 76–80 [CrossRef] [PubMed] [Google Scholar]
  • Choi SH, Hong SB, Ko GB, Lee Y, Park HJ, Park SY, Moon SM, Cho OH, Park KH, Chong YP, Kim SH, Huh JW, Sung H, Do KH, Lee SO, Kim MN, Jeong JY, Lim CM, Kim YS, Woo JH, Koh Y, (2012) Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med 186: 325–332 [CrossRef] [PubMed] [Google Scholar]
  • Luchsinger V, Ruiz M, Zunino E, Martinez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF, (2013) Community-acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax 68: 1000–1006 [CrossRef] [PubMed] [Google Scholar]
  • Karhu J, Ala-Kokko TI, Vuorinen T, Ohtonen P, Syrjala H, (2014) Lower respiratory tract virus findings in mechanically ventilated patients with severe community-acquired pneumonia. Clin Infect Dis 59: 62–70 [CrossRef] [PubMed] [Google Scholar]
  • Voiriot G, Visseaux B, Cohen J, Nguyen LBL, Neuville M, Morbieu C, Burdet C, Radjou A, Lescure FX, Smonig R, Armand-Lefèvre L, Mourvillier B, Yazdanpanah Y, Soubirou JF, Ruckly S, Houhou-Fidouh N, Timsit JF, (2016) Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia. Crit Care 20: 375 [CrossRef] [PubMed] [Google Scholar]
  • Burk M, El-Kersh K, Saad M, Wiemken T, Ramirez J, Cavallazzi R, (2016) Viral infection in community-acquired pneumonia: a systematic review and meta-analysis. Eur Respir Rev 25: 178–188 [CrossRef] [PubMed] [Google Scholar]
  • Miggins M, Hasan A, Hohmann S, Southwick F, Casella G, Schain D, Liu H, Bihorac A, Moldawer L, Efron P, Ang D, (2011) The potential influence of common viral infections diagnosed during hospitalization among critically ill patients in the United States. PLoS One 6: e18890 [CrossRef] [PubMed] [Google Scholar]
  • Jennings LC, Anderson TP, Beynon KA, Chua A, Laing RTR, Werno AM, Young SA, Chambers ST, Murdoch DR, (2008) Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax 63: 42–48 [CrossRef] [PubMed] [Google Scholar]
  • Rice TW, Rubinson L, Uyeki TM, Vaughn FL, John BB, Miller RR, Higgs E, Randolph AG, Smoot BE, Thompson BT; NHLBI ARDS Network, (2012) Critical illness from 2009 pandemic influenza A (H1N1) virus and bacterial co-infection in the United States. Crit Care Med 40: 1487–1498 [CrossRef] [PubMed] [Google Scholar]
  • Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Edwards KM, Schaffner W, Craig AS, Griffin MR, (2005) Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Am J Med 118: 285–291 [CrossRef] [Google Scholar]
  • Peltola V, Heikkinen T, Ruuskanen O, Jartti T, Hovi T, Kilpi T, Vainionpää R, (2011) Temporal association between rhinovirus circulation in the community and invasive pneumococcal disease in children. Pediatr Infect Dis J 30: 456–461 [CrossRef] [PubMed] [Google Scholar]
  • Ampofo K, Bender J, Sheng X, Korgenski K, Daly J, Pavia AT, Byington CL, (2008) Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics 122: 229–237 [CrossRef] [PubMed] [Google Scholar]
  • Blyth CC, Webb SAR, Kok J, Dwyer DE, van Hal SJ, Foo H, Ginn AN, Kesson AM, Seppelt I, Iredell JR, (2013) The impact of bacterial and viral coinfection in severe influenza. Influenza Other Respir Viruses 7: 168–176 [CrossRef] [PubMed] [Google Scholar]
  • McCullers JA, (2006) Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 19: 571–582 [CrossRef] [PubMed] [Google Scholar]
  • Blevins LK, Wren JT, Holbrook BC, Hayward SL, Swords WE, Parks GD, Alexander-Miller MA, (2014) Coinfection with Streptococcus pneumoniae negatively modulates the size and composition of the ongoing influenza-specific CD8+ T cell response. J Immunol Baltim Md 193: 5076–5087 [Google Scholar]
  • Jamieson AM, Pasman L, Yu S, Gamradt P, Homer RJ, Decker T, Medzhitov R, (2013) Role of tissue protection in lethal respiratory viral-bacterial coinfection. Science 340: 1230–1234 [CrossRef] [PubMed] [Google Scholar]
  • Iverson AR, Boyd KL, McAuley JL, Plano LR, Hart ME, McCullers JA, (2011) Influenza virus primes mice for pneumonia from Staphylococcus aureus. J Infect Dis 203: 880–888 [CrossRef] [PubMed] [Google Scholar]
  • Smith CM, Sandrini S, Datta S, Freestone P, Shafeeq S, Radhakrishnan P, Williams G, Glenn SM, Kuipers OP, Hirst RA, Easton AJ, Andrew PW, O’Callaghan C, (2014) Respiratory syncytial virus increases the virulence of Streptococcus pneumoniae by binding to penicillin binding protein 1a. A new paradigm in respiratory infection. Am J Respir Crit Care Med 190: 196–207 [CrossRef] [PubMed] [Google Scholar]
  • Ishizuka S, Yamaya M, Suzuki T, Takahashi H, Ida S, Sasaki T, Inoue D, Sekizawa K, Nishimura H, Sasaki H, (2003) Effects of rhinovirus infection on the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells J Infect Dis 188: 1928–1939 [CrossRef] [PubMed] [Google Scholar]
  • Wolter N, Tempia S, Cohen C, Madhi SA, Venter M, Moyes J, Walaza S, Malope-Kgokong B, Groome M, du Plessis M, Magomani V, Pretorius M, Hellferscee O, Dawood H, Kahn K, Variava E, Klugman KP, von Gottberg A, (2014) High Nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive Pneumococcal pneumonia. J Infect Dis 210: 1649–1657 [CrossRef] [PubMed] [Google Scholar]
  • Salgado CD, Farr BM, Hall KK, Hayden FG, (2002) Influenza in the acute hospital setting. Lancet Infect Dis 2: 145–155 [CrossRef] [PubMed] [Google Scholar]
  • Falsey AR, Walsh EE, (2000) Respiratory syncytial virus infection in adults. Clin Microbiol Rev 13: 371–384 [CrossRef] [PubMed] [Google Scholar]
  • Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DA, (2009) Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis 9: 291–300 [CrossRef] [PubMed] [Google Scholar]
  • Kaiser L, Aubert JD, Pache JC, Deffernez C, Rochat T, Garbino J, Wunderli W, Meylan P, Yerly S, Perrin L, Letovanec I, Nicod L, Tapparel C, Soccal PM, (2006) Chronic rhinoviral infection in lung transplant recipients. Am J Respir Crit Care Med 174: 1392–1399 [CrossRef] [PubMed] [Google Scholar]
  • Byington CL, Ampofo K, Stockmann C, Adler FR, Herbener A, Miller T, Sheng X, Blaschke AJ, Crisp R, Pavia AT, (2015) Community surveillance of respiratory viruses among families in the Utah Better identification of germs-longitudinal viral epidemiology (BIG-LoVE) Study. Clin Infect Dis 61: 1217–1224 [CrossRef] [PubMed] [Google Scholar]
  • de Lima CR, Mirandolli TB, Carneiro LC, Tusset C, Romer CM, Andreolla HF, Baethgen LF, Pasqualotto AC, (2014) Prolonged respiratory viral shedding in transplant patients. Transpl Infect Dis 16: 165–169 [CrossRef] [PubMed] [Google Scholar]
  • Schnell D, Legoff J, Mariotte E, Seguin A, Canet E, Lemiale V, Darmon M, Schlemmer B, Simon F, Azoulay E, (2012) Molecular detection of respiratory viruses in immunocompromised ICU patients: incidence and meaning. Respir Med 106: 1184–1191 [CrossRef] [PubMed] [Google Scholar]
  • Brun-Buisson C, Richard JCM, Mercat A, Thiébaut ACM, Brochard L; REVA-SRLF A/H1N1v 2009 Registry Group, (2011) Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 183: 1200–1206 [CrossRef] [PubMed] [Google Scholar]
  • Zlateva KT, Vries JJC de, Coenjaerts FEJ, Loon AM van, Verheij T, Little P, Butler CC, Goossens H, Ieven M, Claas EC; GRACE Study Group, (2014) Prolonged shedding of rhinovirus and reinfection in adults with respiratory tract illness. Eur Respir J 44: 169–177 [CrossRef] [PubMed] [Google Scholar]
  • Molyneaux PL, Mallia P, Cox MJ, Footitt J, Willis-Owen SA, Homola D, Trujillo-Torralbo MB, Elkin S, Kon OM, Cookson WO, Moffatt MF, Johnston SL, (2013) Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 188: 1224–1231 [CrossRef] [PubMed] [Google Scholar]
  • Hammond SP, Gagne LS, Stock SR, Marty FM, Gelman RS, Marasco WA, Poritz MA, Baden LR, (2012) Respiratory virus detection in immunocompromised patients with FilmArray® respiratory panel compared to conventional methods. J Clin Microbiol 50: 3216–3221 [CrossRef] [PubMed] [Google Scholar]
  • Babady NE, Mead P, Stiles J, Brennan C, Li H, Shuptar S, Stratton CW, Tang YW, Kamboj M, (2012) Comparison of the Luminex xTAG® RVP Fast assay and the Idaho Technology FilmArray ® RP assay for detection of respiratory viruses in pediatric patients at a cancer hospital. J Clin Microbiol 50: 2282–2288 [CrossRef] [PubMed] [Google Scholar]
  • Kim HK, Oh SH, Yun KA, Sung H, Kim MN, (2013) Comparison of Anyplex II RV16 with the xTAG® respiratory viral panel and Seeplex RV15 for detection of respiratory viruses. J Clin Microbiol 51: 1137–1141 [CrossRef] [PubMed] [Google Scholar]
  • Nolte FS, Marshall DJ, Rasberry C, Schievelbein S, Banks GG, Storch GA, Arens MQ, Buller RS, Prudent JR, (2007) MultiCode-PLx system for multiplexed detection of seventeen respiratory viruses. J Clin Microbiol 45: 2779–2786 [CrossRef] [PubMed] [Google Scholar]
  • van Elden LJR, van Kraaij MGJ, Nijhuis M, Hendriksen KAW, Dekker AW, Rozenberg-Arska M, van Loon AM, (2002) Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with hematological cancer and pneumonia. Clin Infect Dis 34: 177–183 [CrossRef] [PubMed] [Google Scholar]
  • Babady NE, (2013) The FilmArray® respiratory panel: an automated, broadly multiplexed molecular test for the rapid and accurate detection of respiratory pathogens. Expert Rev Mol Diagn 13: 779–788 [CrossRef] [PubMed] [Google Scholar]
  • Pillet S, Lardeux M, Dina J, Grattard F, Verhoeven P, Goff JL, Vabret A, Pozzetto B, (2013) Comparative evaluation of six commercialized multiplex PCR kits for the diagnosis of respiratory infections. PLoS One 8: e72174 [Google Scholar]
  • Vallières E, Renaud C, (2013) Clinical and economical impact of multiplex respiratory virus assays. Diagn Microbiol Infect Dis 76: 255–261 [CrossRef] [Google Scholar]
  • Visseaux B, Collin G, Ichou H, Charpentier C, Bendhafer S, Dumitrescu M, Allal L, Cojocaru B, Desfrère L, Descamps D, Mandelbrot L, Houhou-Fidouh N, (2017) Usefulness of multiplex PCR methods and respiratory viruses’ distribution in children below 15 years old according to age, seasons and clinical units in France: a 3-year retrospective study. PloS One 12: e0172809 [CrossRef] [PubMed] [Google Scholar]
  • Visseaux B, Burdet C, Voiriot G, Lescure FX, Chougar T, Brugière O, Crestani B, Casalino E, Charpentier C, Descamps D, Timsit JF, Yazdanpanah Y, Houhou-Fidouh N, (2017) Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016. PloS One 12: e0180888 [CrossRef] [PubMed] [Google Scholar]
  • Yu X, Lu R, Wang Z, Zhu N, Wang W, Julian D, Chris B, Lu J, Tan W, (2012) Etiology and clinical characterization of respiratory virus infections in adult patients attending an emergency department in Beijing. PloS One 7: e32174 [CrossRef] [PubMed] [Google Scholar]
  • Das D, Le Floch H, Houhou N, Epelboin L, Hausfater P, Khalil A, Ray P, Duval X, Claessens YE, Leport C; ESCAPED Study Group, (2015) Viruses detected by systematic multiplex polymerase chain reaction in adults with suspected community-acquired pneumonia attending emergency departments in France. Clin Microbiol Infect 21: 608.e1–608 [Google Scholar]
  • Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, Reed C, Grijalva CG, Anderson EJ, Courtney DM, Chappell JD, Qi C, Hart EM, Carroll F, Trabue C, Donnelly HK, Williams DJ, Zhu Y, Arnold SR, Ampofo K, Waterer GW, Levine M, Lindstrom S, Winchell JM, Katz JM, Erdman D, Schneider E, Hicks LA, McCullers JA, Pavia AT, Edwards KM, Finelli L; CDC EPIC Study Team, (2015) Community-acquired pneumonia requiring hospitalization among US Adults. N Engl J Med 373: 415–427 [CrossRef] [PubMed] [Google Scholar]
  • Choi SH, Hong SB, Ko GB, Lee Y, Park HJ, Park SY, Moon SM, Cho OH, Park KH, Chong YP, Kim SH, Huh JW, Sung H, Do KH, Lee SO, Kim MN, Jeong JY, Lim CM, Kim YS, Woo JH, Koh Y, (2012) Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med 186: 325–332 [CrossRef] [PubMed] [Google Scholar]
  • Voiriot G, Visseaux B, Cohen J, Nguyen LBL, Neuville M, Morbieu C, Burdet C, Radjou A, Lescure FX, Smonig R, Armand-Lefèvre L, Mourvillier B, Yazdanpanah Y, Soubirou JF, Ruckly S, Houhou-Fidouh N, Timsit JF, (2016) Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia. Crit Care 20: 375 [CrossRef] [PubMed] [Google Scholar]
  • Loubet P, Voiriot G, Houhou-Fidouh N, Neuville M, Bouadma L, Lescure FX, Descamps D, Timsit JF, Yazdanpanah Y, Visseaux B, (2017) Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: a single-center retrospective study. J Clin Virol 91: 52–57 [CrossRef] [PubMed] [Google Scholar]
  • Hong HL, Hong SB, Ko GB, Huh JW, Sung H, Do KH, Kim SH, Lee SO, Kim MN, Jeong JY, Lim CM, Kim YS, Woo JH, Koh Y, Choi SH, (2014) Viral infection is not uncommon in adult patients with severe hospital-acquired pneumonia. PLoS One 9: e95865 [CrossRef] [PubMed] [Google Scholar]
  • Loubet P, Loulergue P, Galtier F, Launay O, (2016) Seasonal influenza vaccination of high-risk adults. Expert Rev Vaccines 15: 1507–1518 [CrossRef] [PubMed] [Google Scholar]
  • Guthmann JP, Fonteneau L, Ciotti C, Bouvet E, Pellissier G, Lévy-Bruhl D, Abiteboul D, (2011) Couverture vaccinale des soignants travaillant dans les établissements de soins de France. Résultats de l’enquête nationale Vaxisoin, 2009. Bull Epidemiol Hebd 35–36: 376–378 [Google Scholar]
  • Ahmed F, Lindley MC, Allred N, Weinbaum CM, Grohskopf L, (2014) Effect of influenza vaccination of healthcare personnel on morbidity and mortality among patients: systematic review and grading of evidence. Clin Infect Dis 58: 50–57 [CrossRef] [PubMed] [Google Scholar]
  • Seto WH, Tsang D, Yung RWH, Ching TY, Ng TK, Ho M, Ho LM, Peiris JS; Advisors of Expert SARS group of Hospital Authority, (2003) Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet Lond Engl 361: 1519–1520 [CrossRef] [Google Scholar]
  • Warren-Gash C, Fragaszy E, Hayward AC, (2013) Hand hygiene to reduce community transmission of influenza and acute respiratory tract infection: a systematic review. Influenza Other Respir Viruses 7: 738–749 [CrossRef] [PubMed] [Google Scholar]
  • Jefferson T, Del Mar CB, Dooley L, Ferroni E, Al-Ansary LA, Bawazeer GA, van Driel ML, Nair S, Jones MA, Thorning S, Conly JM, (2011) Physical interventions to interrupt or reduce the spread of respiratory viruses [Internet]. In: Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd; [cité le 1er mars 2018]. Available from: http://onlinelibrary.wiley.com.gate2.inist.fr/doi/10.1002/14651858.CD006207.pub4/abstract [Google Scholar]
  • Simon A, Khurana K, Wilkesmann A, Müller A, Engelhart S, Exner M, Schildgen O, Eis-Hübinger AM, Groothuis JR, Bode U, (2006) Nosocomial respiratory syncytial virus infection: impact of prospective surveillance and targeted infection control. Int J Hyg Environ Health 209: 317–324 [CrossRef] [PubMed] [Google Scholar]
  • HCSP, (2015) Prévention de la grippe et des infections respiratoires virales saisonnières [Internet]. Haut Conseil de la santé publique, Paris [cité le 1er mars 2018]. Available from: https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=522 [Google Scholar]
  • Actualisation des précautions standard [Internet]. SF2H [cité le 1er mars 2018] Available from: https://sf2h.net/publications/actualisation-precautions-standard-2017 [Google Scholar]
  • Chan-Tack KM, Kim C, Moruf A, Birnkrant DB, (2015) Clinical experience with intravenous zanamivir under an Emergency IND program in the United States (2011–2014) Antivir Ther 20: 561–564 [CrossRef] [PubMed] [Google Scholar]
  • Marty FM, Vidal-Puigserver J, Clark C, Gupta SK, Merino E, Garot D, Chapman MJ, Jacobs F, Rodriguez-Noriega E, Husa P, Shortino D, Watson HA, Yates PJ, Peppercorn AF, (2017) Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, doubledummy, phase 3 trial. Lancet Respir Med 5: 135–146 [CrossRef] [Google Scholar]
  • Watanabe A, Chang SC, Kim MJ, Chu DW, Ohashi Y, (2010) Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: a double-blind, randomized, non-inferiority clinical trial. Clin Infect Dis 51: 1167–1175 [CrossRef] [PubMed] [Google Scholar]
  • Moss RB, Hansen C, Sanders RL, Hawley S, Li T, Steigbigel RT, (2012) A phase 2 study of DAS181, a novel host directed antiviral for the treatment of influenza infection. J Infect Dis 206: 1844–1851 [CrossRef] [PubMed] [Google Scholar]
  • Beaird OE, Freifeld A, Ison MG, Lawrence SJ, Theodoropoulos N, Clark NM, Razonable RR, Alangaden G, Miller R, Smith J, Young JA, Hawkinson D, Pursell K, Kaul DR, (2016) Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern respiratory virus collaborative. Transpl Infect Dis 18: 210–215 [CrossRef] [PubMed] [Google Scholar]
  • Gross AE, Bryson ML, (2015) Oral ribavirin for the treatment of noninfluenza respiratory viral infections: a systematic review. Ann Pharmacother 49: 1125–1135 [CrossRef] [PubMed] [Google Scholar]
  • Neemann K, Freifeld A, (2015) Respiratory syncytial virus in hematopoietic stem cell transplantation and solid-organ transplantation. Curr Infect Dis Rep 17: 490 [CrossRef] [PubMed] [Google Scholar]
  • Heylen E, Neyts J, Jochmans D, (2017) Drug candidates and model systems in respiratory syncytial virus antiviral drug discovery. Biochem Pharmacol 127: 1–12 [CrossRef] [PubMed] [Google Scholar]
  • Gottlieb J, Zamora MR, Hodges T, Musk AW, Sommerwerk U, Dilling D, Arcasoy S, DeVincenzo J, Karsten V, Shah S, Bettencourt BR, Cehelsky J, Nochur S, Gollob J, Vaishnaw A, Simon AR, Glanville AR, (2016) ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients. J Heart Lung Transplant 35: 213–221 [CrossRef] [Google Scholar]
  • DeVincenzo JP, Whitley RJ, Mackman RL, Scaglioni-Weinlich C, Harrison L, Farrell E, McBride S, Lambkin-Williams R, Jordan R, Xin Y, Ramanathan S, O’Riordan T, Lewis SA, Li X, Toback SL, Lin SL, Chien JW, (2014) Oral GS-5806 activity in a respiratory syncytial virus challenge study. N Engl J Med 371: 711–722 [CrossRef] [PubMed] [Google Scholar]
  • DeVincenzo JP, McClure MW, Symons JA, Fathi H, Westland C, Chanda S, Lambkin-Williams R, Smith P, Zhang Q, Beigelman L, Blatt LM, Fry J, (2015) Activity of oral ALS-008176 in a respiratory syncytial virus challenge study. N Engl J Med 373: 2048–2058 [CrossRef] [PubMed] [Google Scholar]
  • Weigt SS, Gregson AL, Deng JC, Lynch JP, Belperio JA, (2011) Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients. Semin Respir Crit Care Med 32: 471–493 [CrossRef] [PubMed] [Google Scholar]
  • Salvatore M, Satlin MJ, Jacobs SE, Jenkins SG, Schuetz AN, Moss RB, Van Besien K, Shore T, Soave R, (2016) DAS181 for treatment of parainfluenza virus infections in hematopoietic stem cell transplant recipients at a single center. Biol Blood Marrow Transplant 22: 965–970 [CrossRef] [PubMed] [Google Scholar]
  • Shah DP, Shah PK, Azzi JM, El Chaer F, Chemaly RF, (2016) Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: a systematic review. Cancer Lett 379: 100–106 [CrossRef] [Google Scholar]
  • Hayden FG, Herrington DT, Coats TL, Kim K, Cooper EC, Villano SA, Liu S, Hudson S, Pevear DC, Collett M, McKinlay M; Pleconaril Respiratory Infection Study Group, (2003) Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials. Clin Infect Dis 36: 1523–1532 [CrossRef] [PubMed] [Google Scholar]
  • Matz J, (2013) Vapendavir for the treatment of naturally acquired rhinovirus infection in asthmatic adults: effect on asthma control in a phase 2 clinical trial [Internet]. In: D31. Respiratory tract infection and inflammation: from animal models to human studies. American Thoracic Society; [cité le 22 février 2018]. Pages A5497–A5497. Available from: https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A5497 [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.